Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$427M |
| 2 |
Roku
ROKU
|
+$393M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$345M |
| 4 |
AT&T
T
|
+$317M |
| 5 |
Qualcomm
QCOM
|
+$293M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.41B |
| 2 |
Pinduoduo
PDD
|
+$755M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$716M |
| 4 |
AbbVie
ABBV
|
+$558M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$491M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Technology | 17.52% |
| 3 | Communication Services | 11.4% |
| 4 | Consumer Discretionary | 10.59% |
| 5 | Consumer Staples | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.16B
| $1.32M | ﹤0.01% |
17,100
-70,700
| -81% | -$5.62M |
|
2477
ResMed
RMD
$32.4B
| $1.32M | ﹤0.01% |
6,887
+3,680
| +115% | +$738K |
|
2478
Genprex
GNPX
$2.24M
| $1.32M | ﹤0.01% |
+7
| New | +$1.54M |
|
2479
iShares International Treasury Bond ETF
IGOV
$1.54B
| $1.32M | ﹤0.01% |
25,400
+5,606
| +28% | +$302K |
|
|
EFC
2480
Ellington Financial
EFC
$1.65B
| $1.32M | ﹤0.01% |
82,300
-31,500
| -28% | -$497K |
|
|
IFLN
2481
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$306M
| $1.32M | ﹤0.01% |
68,066
-68,834
| -50% | -$1.33M |
|
|
AC
2482
DELISTED
Associated Capital Group
AC
| $1.31M | ﹤0.01% |
36,575
-2,925
| -7% | -$104K |
|
2483
Precision BioSciences
DTIL
$191M
| $1.31M | ﹤0.01% |
4,215
+2,977
| +240% | +$1.04M |
|
2484
Astrana Health
ASTH
$1.69B
| $1.3M | ﹤0.01% |
47,900
-8,500
| -15% | -$204K |
|
|
TBI
2485
Trueblue
TBI
$310M
| $1.29M | ﹤0.01% |
58,800
+16,600
| +39% | +$340K |
|
|
THER
2486
DELISTED
THERATECHNOLOGIES INC COM
THER
| $1.29M | ﹤0.01% |
335,000
+204,894
| +157% | +$792K |
|
2487
Nordson
NDSN
$17.2B
| $1.29M | ﹤0.01% |
+6,514
| New | +$1.27M |
|
|
NVEE
2488
DELISTED
NV5 Global
NVEE
| $1.29M | ﹤0.01% |
+53,580
| New | +$1.28M |
|
2489
Cartesian Therapeutics
RNAC
$257M
| $1.29M | ﹤0.01% |
9,483
-22,891
| -71% | -$2.84M |
|
2490
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.27B
| $1.28M | ﹤0.01% |
35,500
-400
| -1% | -$14.2K |
|
|
CATC
2491
DELISTED
CAMBRIDGE BANCORP
CATC
| $1.28M | ﹤0.01% |
15,241
-6,332
| -29% | -$496K |
|
2492
TAT Technologies
TATT
$518M
| $1.28M | ﹤0.01% |
249,600
+7,300
| +3% | +$42K |
|
2493
Minerva Neurosciences
NERV
$207M
| $1.28M | ﹤0.01% |
54,888
-30,893
| -36% | -$772K |
|
2494
CNA Financial
CNA
$14.2B
| $1.28M | ﹤0.01% |
28,699
-279,200
| -91% | -$11.9M |
|
2495
Hennessy Advisors
HNNA
$78.4M
| $1.28M | ﹤0.01% |
148,336
+18,507
| +14% | +$162K |
|
2496
Twin Disc
TWIN
$337M
| $1.28M | ﹤0.01% |
133,593
-62,400
| -32% | -$554K |
|
|
STR
2497
DELISTED
Sitio Royalties
STR
| $1.27M | ﹤0.01% |
70,975
+18,249
| +35% | +$290K |
|
2498
iShares Core MSCI Europe ETF
IEUR
$9.08B
| $1.27M | ﹤0.01% |
23,600
+16,200
| +219% | +$859K |
|
|
SCPH
2499
DELISTED
scPharmaceuticals
SCPH
| $1.27M | ﹤0.01% |
191,386
-55,700
| -23% | -$382K |
|
|
CVSA
2500
Covista Inc
CVSA
$4.23B
| $1.27M | ﹤0.01% |
+32,100
| New | +$1.25M |
|
Similar funds
Renaissance Technologies's Q1 2021 Portfolio in Review
As of Q1 2021, Renaissance Technologies held 3,937 positions worth $80.4B, down 13% from $92.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies withdrew a net $16B in Q1 2021, closing 676 positions and reducing 1,579 holdings. Its most notable exit was Micron Technology, an estimated $252M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Renaissance Technologies opened a new position in Paramount Global Class B worth $255M.
- Renaissance Technologies's largest Q1 2021 buy was Paramount Global Class B: 5,644,997 shares worth $255M.
- Renaissance Technologies added most to Tesla in Q1 2021, an estimated $427M increase.
- Renaissance Technologies's biggest Q1 2021 reduction was Baidu, cutting an estimated $1.41B.
- Renaissance Technologies fully exited Micron Technology in Q1 2021, selling an estimated $252M.
- Renaissance Technologies's ten largest holdings make up 10% of its $80.4B portfolio in Q1 2021.
- Renaissance Technologies opened 591 new positions and closed 676 in Q1 2021.
- Renaissance Technologies's portfolio value fell 13% quarter-over-quarter to $80.4B.
Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.